COVID-19 Federal Response Update – Thursday, April 23, 2020

Posted by

By Capitol Associates, Inc. 

    • By the end of the evening, the House will have passed bipartisan legislation that provides an additional $320 billion funding to the Small Business Association (SBA) for its Paycheck Protection Program (PPP) and other disaster aid programs. The bill includes certain conditions for the PPP funding so that $60 billion of the funding is distributed to small and medium sized lenders. It also provides more funding for the SBA’s Economic Injury Disaster Loan program (EIDL). Both the PPP and the EIDL completely distributed the funding it received in the CARES Act.
    • The bill also provides $75 billion to the Department of Health and Human Services (HHS) to distribute throughout the healthcare system.
    • In response to criticisms that large, publicly traded companies were receiving PPP loans, the SBA issued new guidance to clarify that those companies will not be eligible. However, in some notable cases, the recipients were independent franchises of the publicly traded company.
    • The Centers for Medicare and Medicaid Services (CMS) published a new Telehealth Toolkit to help providers understand all the new flexibilities for telehealth policies at the federal level.
    • The Centers for Disease Control and Prevention (CDC) distributed an additional $631 million to 64 jurisdictions to support local epidemiology and public health efforts. The full list of CDC funding awards to states and territories is available through the CDC’s website.
    • Anthony Fauci, Director of the National Institute of Allergy and Infectious Disease, said the country needs a greater testing capacity before social distancing guidelines can be lifted.
    • CDC Director Dr. Robert Redfield is clarifying remarks he made about the challenges of a second COVID-19 wave in the fall. He disagreed with some media outlets for interpreting his remarks to mean that a fall wave would be worse than the current wave. However, his remarks were intended to describe the challenges of combatting COVID-19 during the height of the fall flu season.
    • A panel of researchers from the National Institute of Allergy and Infectious Disease (NIAID) recommended against the use of malaria drug hydroxychloroquine in combination with azithromycin to treat COVID-19.
    • President Trump signed an Executive Order that suspends most immigration into the United States during the public health emergency. The Order does not impact immigrants who are currently in the country. The government has already taken other actions to limit immigration such as suspending the visa process and temporarily closing the U.S. border with Mexico and Canada to non-essential travel.
    • Yesterday’s Daily Update highlighted an Internal Revenue Service (IRS) webinar that was scheduled for today. This morning, the IRS postponed that webinar. The IRS did not announce a new date for the webinar.
    • The Occupational Safety and Health Administration (OSHA) is investigating work place safety issues at healthcare facilities. However, it will reserve enforcing penalties for the most egregious violations.


Post a Comment

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s